OR6R2P

Across TCGA pan-cancer cohorts, OR6R2P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated OR6R2P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher OR6R2P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR6R2P expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

KICH, CHOL, and KIRC are the cancer types where OR6R2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.474	0.941	<.001	105	view →
CHOL	DFS	Tertile	II,III,IV	0.016	0.406	<.001	72	view →
KIRC	DFS	Quartile	IV	0.205	0.561	.006	56	view →
THCA	OS	Tertile	All	0.752	0.989	<.001	51	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
LUSC	OS	Tertile	III,IV	0.240	0.585	.012	36	view →
ACC	DFS	Tertile	All	0.137	0.771	<.001	36	view →
SKCM	OS	Tertile	IV	0.323	0.804	<.001	27	view →
THYM	DFS	Tertile	II,III,IV	0.619	0.913	.004	21	view →
STAD	DFS	Tertile	II,III,IV	0.541	0.727	.043	9	view →
SARC	OS	Tertile	All	0.221	0.531	.016	9	view →
PCPG	OS	Tertile	All	0.796	0.977	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

OR6R2P–KICH (DFS)

Open the KICH breakdown →